PROVIDER PROFILE · NPI 1720015498

Robert McmurrayMD

RheumatologyJackson, MSI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,972

Unique beneficiaries

—

Total services

9,704

Distinct HCPCS

Medicare payment

$123K

Peer benchmark

Total Medicare services vs. 28 Rheumatology providers in MS — above median (cohort median 5,807).

PRESCRIBING · PART D · 2024

Total Rx claims

1,950

Beneficiaries

—

Total drug cost

$466K

Distinct drugs

Brand share

14.8%

Top prescribed drugs

Hydroxychloroquine Sulfate394 claims

Methotrexate Sodium131 claims

Prednisone96 claims

Meloxicam94 claims

Trazodone Hcl91 claims

QUALITY · MIPS · 2024

Final MIPS score

23.4

Quality

0.0

Cost

77.9

Improvement activities

0.0

Promoting interop.

0.0

Payment adjustment

-6.20%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

By payment type

Food and Beverage$2K

REFERRAL NETWORK

Where Robert Mcmurray's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL	140	305
ST DOMINIC-JACKSON MEMORIAL HOSPITAL	41	106
MADISON RADIOLOGICAL GROUP LLC	21	41
STATE OF MISSISSIPPI - UNIVERSITY OF MISSISSIPPI MEDICAL CENTER	18	28
RIVER OAKS HOSPITAL LLC	15	25
Miriam Shatley Dermatology · Flowood, MS	13	17

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history